A new wave of medicines has emerged in recent years, to supplement the established small and large molecule platforms. These complex medicines will become as important as traditional small molecule drugs in the coming years, with market values of hundreds of billions of pounds.
We partnered with CPI to engage stakeholders across the UK, through surveys and interviews, to develop an understanding of the complex medicines landscape, the challenges encountered by those working in this area, and to develop clear recommendations to support the sector for national growth and impact in this space.
Download our State of the Discovery Nation 2021 report to get a more in-depth look into complex medicines.
